These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35365491)

  • 1. One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis.
    Tanner A; Haddad F; Fajardo-Sanchez J; Nguyen E; Thong KX; Ah-Moye S; Perl N; Abu-Bakra M; Kulkarni A; Trikha S; Lascaratos G; Parnell M; Kailani O; King AJ; Agrawal P; Stead R; Giannouladis K; Rodrigues I; Goyal S; Hysi PG; Lim S; Yu-Wai-Man C
    Br J Ophthalmol; 2023 Aug; 107(8):1104-1111. PubMed ID: 35365491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom.
    Van Lancker L; Saravanan A; Abu-Bakra M; Reid K; Quijano C; Goyal S; Rodrigues I; Lascaratos G; Trikha S; Barwood C; Combe E; Kulkarni A; Lim KS; Low S
    Ophthalmol Glaucoma; 2023; 6(4):342-357. PubMed ID: 36427750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device-modified trabeculectomy for glaucoma.
    Park J; Rittiphairoj T; Wang X; E JY; Bicket AK
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010472. PubMed ID: 36912740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle Glaucoma: Three-Year Results as a Primary Surgical Intervention.
    Armstrong JJ; De Francesco T; Ma J; Schlenker MB; Ahmed IIK
    Ophthalmol Glaucoma; 2023; 6(5):480-492. PubMed ID: 37044278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma.
    Strzalkowska A; Strzalkowski P; Hoffmann EM; Pfeiffer N; Schuster AK
    J Glaucoma; 2023 Aug; 32(8):681-685. PubMed ID: 37327469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study.
    Beckers HJM; Aptel F; Webers CAB; Bluwol E; Martínez-de-la-Casa JM; García-Feijoó J; Lachkar Y; Méndez-Hernández CD; Riss I; Shao H; Pinchuk L; Angeles R; Sadruddin O; Shaarawy TM
    Ophthalmol Glaucoma; 2022; 5(2):195-209. PubMed ID: 34329772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study.
    Bhayani R; Martínez de la Casa JM; Figus M; Klabe K; Rabiolo A; Mercieca K
    Eye (Lond); 2023 Mar; 37(4):644-649. PubMed ID: 35277663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of the Preserflo
    Majoulet A; Scemla B; Hamard P; Brasnu E; Hage A; Baudouin C; Labbé A
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498660
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C.
    Schlenker MB; Durr GM; Michaelov E; Ahmed IIK
    Am J Ophthalmol; 2020 Jul; 215():141-153. PubMed ID: 32173344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year outcomes of stand-alone ab externo SIBS microshunt implantation in refractory glaucoma.
    Durr GM; Schlenker MB; Samet S; Ahmed IIK
    Br J Ophthalmol; 2022 Jan; 106(1):71-79. PubMed ID: 33097520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
    Baker ND; Barnebey HS; Moster MR; Stiles MC; Vold SD; Khatana AK; Flowers BE; Grover DS; Strouthidis NG; Panarelli JF;
    Ophthalmology; 2021 Dec; 128(12):1710-1721. PubMed ID: 34051211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study.
    Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L
    Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes.
    Triolo G; Wang J; Aguilar-Munoa S; Jayaram H; Barton K
    Eye (Lond); 2023 Aug; 37(12):2535-2541. PubMed ID: 36577805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of the PreserFlo implant with mitomycin C in childhood glaucoma after previous failed glaucoma surgeries.
    Burgos-Blasco B; García-Feijóo J; Gines-Gallego C; Perucho-Gonzalez L; Fernandez-Vigo JI; Martinez de la Casa JM; Saenz-Frances F; Morales-Fernandez L; Mendez-Hernandez CD
    Graefes Arch Clin Exp Ophthalmol; 2023 May; 261(5):1349-1357. PubMed ID: 36536223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Year Outcomes of Preserflo
    Nobl M; Grün C; Kassumeh S; Priglinger S; Mackert MJ
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, Confounders and Safety of the Preserflo Microshunt.
    Altas C; Fuchsluger TA; Brockmann T; Graumüller A; Walckling M
    Klin Monbl Augenheilkd; 2024 Sep; 241(9):1048-1056. PubMed ID: 39047762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.
    Mandal AK; Bagga H; Nutheti R; Gothwal VK; Nanda AK
    Eye (Lond); 2003 Jan; 17(1):53-62. PubMed ID: 12579171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety.
    Jamke M; Herber R; Haase MA; Jasper CS; Pillunat LE; Pillunat KR
    Graefes Arch Clin Exp Ophthalmol; 2023 Oct; 261(10):2901-2915. PubMed ID: 37133501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma.
    Seuthe AM; Erokhina M; Szurman P; Haus A
    J Glaucoma; 2023 May; 32(5):414-419. PubMed ID: 36795529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypotony in the early postoperative period after MicroShunt implantation versus trabeculectomy: A registry study.
    Bøhler AD; Traustadóttir VD; Hagem AM; Tønset TS; Drolsum L; Kristianslund O
    Acta Ophthalmol; 2024 Mar; 102(2):186-191. PubMed ID: 37340695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.